Bronchial asthma affects more than 300 million individuals worldwide and represents one of the most prevalent chronic non-communicable diseases, imposing substantial healthcare costs and quality of life burden.¹ Despite significant pharmacological advances — including inhaled corticosteroids, long-acting beta-2 agonists, leukotriene receptor antagonists, and biologic agents — a considerable proportion of patients continue to experience persistent symptoms, exercise limitation, and psychological distress.² Long-term medication dependence is associated with adverse effects, patient fatigue, and healthcare expenditure.³ These limitations have stimulated substantial research interest in non-pharmacological adjunct therapies. Breathing exercises — structured respiratory training techniques designed to optimise breathing patterns, strengthen respiratory muscles, and improve ventilation — represent perhaps the most clinically accessible and evidence-supported among these interventions.⁴ They require no pharmaceutical expenditure, carry minimal adverse effects, can be self-administered following initial instruction, and address multiple pathophysiological dimensions of asthma simultaneously. Nevertheless, incorporation of breathing exercises into routine clinical practice remains inconsistent. Barriers include heterogeneity in published protocols, variability in reported outcomes, limited familiarity among prescribing clinicians, and absence of standardised guideline recommendations.⁵ A clear mechanistic and evidence-based framework is needed to support clinician decision-making and patient communication. This review addresses that need by: (i) outlining the respiratory biomechanics and physiological rationale underpinning each major breathing exercise modality; (ii) critically appraising clinical trial and systematic review evidence; (iii) proposing an integrative physiological framework; and (iv) identifying research gaps and clinical implementation considerations. 2. PATHOPHYSIOLOGY OF ASTHMA RELEVANT TO BREATHING EXERCISE THERAPY Understanding the pathophysiological basis of asthma is essential for appreciating how breathing exercises exert their therapeutic effects. 2.1 Airway Inflammation and Obstruction Asthma is characterised by chronic airway mucosal inflammation involving eosinophils, mast cells, T helper type 2 (Th2) lymphocytes, and innate lymphoid cells (ILC2). Th2-mediated cytokines — particularly interleukin (IL)-4, IL-5, and IL-13 — drive eosinophilic inflammation, IgE production, mucus hypersecretion, and airway smooth muscle hyperresponsiveness.⁶ The resultant airway narrowing, mucosal oedema, and mucus plugging collectively reduce airway patency and increase resistance to airflow. 2.2 Respiratory Mechanical Consequences Increased airway resistance in asthma elevates the work of breathing and leads to respiratory muscle fatigue. Incomplete expiration causes air trapping and dynamic hyperinflation, placing the diaphragm at a mechanical disadvantage and further reducing inspiratory muscle efficiency. Accessory muscles are recruited to compensate, increasing energy expenditure and worsening dyspnoea.⁷ The resultant rapid shallow breathing pattern further reduces ventilatory efficiency and worsens ventilation-perfusion mismatch. 2.3 Autonomic and Neurological Dysregulation Autonomic imbalance — characterised by increased parasympathetic and reduced sympathetic tone — contributes to bronchial smooth muscle hypercontractility. Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system, triggering catecholamine release and heightened bronchomotor tone. Breathing exercises have been shown to favourably modulate autonomic balance, increasing parasympathetic activity and reducing sympathetic tone.⁸ 2.4 Psychological and Behavioural Dimensions Anxiety and psychological stress are recognised triggers for asthma exacerbations and are prevalent among asthma patients. Dysfunctional breathing patterns — including hyperventilation and chronic hypocapnia — are common in anxiety-associated asthma and can precipitate bronchoconstriction via reduced carbon dioxide levels.⁹ Breathing retraining addresses these psychological-respiratory interactions directly. 3. MAJOR BREATHING EXERCISE MODALITIES: MECHANISMS AND EVIDENCE 3.1 Diaphragmatic Breathing 3.1.1 Physiological Mechanism Diaphragmatic (abdominal) breathing promotes efficient use of the diaphragm — the primary inspiratory muscle responsible for 70–80% of inspiratory effort under resting conditions — by conditioning it through repeated controlled contractions. This technique increases diaphragmatic excursion and tidal volume, reduces reliance on energy-inefficient accessory muscles, slows the respiratory rate, prolongs expiratory time to reduce dynamic air trapping, and shifts ventilation toward under-ventilated lung units, improving the ventilation-perfusion (V/Q) ratio.¹⁰ Biomechanically, improved diaphragmatic function reduces thoracic hyperinflation, restores the dome shape and mechanical advantage of the diaphragm, and decreases the intrinsic positive end-expiratory pressure (PEEPi) associated with air trapping in obstructive disease.¹¹ 3.1.2 Clinical Evidence Cooper et al. demonstrated improved lung volumes, tidal volume, and reduced respiratory muscle fatigue following diaphragmatic breathing training in asthma patients. Lopes et al. reported significant FVC improvements following a 12-week programme, attributing gains to increased tidal volume and reduced residual volume.¹² A systematic review by Cahalin et al. confirmed that diaphragmatic breathing improves ventilatory mechanics in obstructive airway diseases, with a consistent positive effect on FVC and FEV1.¹³ 3.2 Pursed-Lip Breathing 3.2.1 Physiological Mechanism PLB involves slow exhalation through partially closed (pursed) lips, creating a mild resistive back-pressure within the airways equivalent to a low-level positive end-expiratory pressure (PEEP). This back-pressure stents open medium and small bronchioles during exhalation, prevents premature expiratory airway collapse, slows expiratory flow, prolongs exhalation time, and reduces air trapping and dynamic hyperinflation. The net effect is improved lung emptying, reduced functional residual capacity, and improved FEV1/FVC ratios.¹⁴ Additionally, PLB activates the parasympathetic nervous system by prolonging the expiratory phase, reducing respiratory rate, and lowering sympathetic tone — contributing to bronchodilation and dyspnoea relief.¹⁵ 3.2.2 Clinical Evidence Mueller et al. demonstrated that PLB improves ventilation and reduces dead space ventilation in obstructive lung disease.¹⁶ Clinical trials in asthma have documented significant reductions in dyspnoea scores and improvements in oxygen saturation following PLB training. Spahija et al. confirmed that PLB reduces hyperinflation and work of breathing, improving exercise capacity.¹⁷ 3.3 Buteyko Breathing Technique 3.3.1 Physiological Mechanism Developed by the Russian physician Konstantin Buteyko, this technique is predicated on the Bohr effect: chronic hyperventilation reduces arterial CO₂ (hypocapnia), shifting the oxyhaemoglobin dissociation curve leftward and promoting bronchospasm via a direct effect on bronchial smooth muscle. Buteyko training uses controlled shallow nasal breathing, extended breath-holding exercises (control pause), and reduced breathing rate to restore eucapnia (normal CO₂ levels), thereby reducing bronchomotor tone and airway hyperresponsiveness.¹⁸ 3.3.2 Clinical Evidence Bowler et al. conducted a randomised clinical trial demonstrating significant reductions in bronchodilator use and symptom severity following Buteyko training.¹⁹ Cowie et al. confirmed reduced bronchodilator requirements and improved asthma control scores.²⁰ Prem et al. compared Buteyko and Pranayama techniques, reporting improvements in quality of life with both, though objective spirometric changes were variable.²¹ A Cochrane review reported Buteyko training significantly reduces reliever medication use and improves asthma symptoms, though its effect on FEV1 is inconsistent.²² 3.4 Yoga-Based Pranayama Techniques 3.4.1 Physiological Mechanisms Pranayama encompasses a family of controlled yogic breathing practices. The three techniques most studied in asthma management each offer distinct mechanistic contributions: Anulom-Vilom (Alternate Nostril Breathing): Alternate inhalation and exhalation through each nostril improves nasal airflow symmetry, enhances parasympathetic tone via stimulation of nasal receptors, and reduces sympathetic nervous system hyperactivity. Paul et al. demonstrated significant improvements in heart rate variability (a marker of autonomic balance) following Anulom-Vilom practice.²³ Bhramari Pranayama (Humming Bee Breathing): Exhalation with humming sound generation creates nasal sinus resonance that substantially increases endogenous nasal nitric oxide (NO) production. As a potent bronchodilator and vasodilator, increased NO bioavailability directly improves airway patency and reduces vascular resistance.²⁴ Kapalbhati (Forceful Exhalation): Rapid, repetitive forceful exhalations with passive inhalation train and strengthen expiratory abdominal and intercostal muscles, facilitate airway secretion clearance, improve functional residual capacity, and enhance expiratory flow rates.²⁵ 3.4.2 Clinical Evidence Nagarathna and Nagendra conducted one of the earliest RCTs demonstrating significant PEFR improvements and reduced asthma attack frequency following a six-week integrated yoga programme.²⁶ Singh et al. reported improved FEV1 and reduced airway reactivity following Pranayama training.²⁷ Vempati et al. demonstrated significant improvements in FVC, FEV1, and quality of life following a comprehensive yoga-based lifestyle programme.²⁸ A Cochrane meta-analysis by Yang et al. reviewed 15 RCTs and found that yoga significantly improves lung function parameters and quality of life in asthma patients, though heterogeneity in protocols limits generalisability.²⁹ Cramer et al.'s meta-analysis similarly concluded that yoga improves lung function and quality of life, with an acceptable safety profile.³⁰ 4. COMPARATIVE EVIDENCE SUMMARY Table 1 provides a structured comparison of the four major breathing exercise modalities across mechanistic and clinical dimensions. Table 1. Comparative Summary of Breathing Exercise Modalities in Asthma Modality Primary Mechanism Key Clinical Benefit Effect on FEV1 Quality of Evidence Diaphragmatic Breathing Diaphragm conditioning; ↑ tidal volume; ↓ air trapping FVC, FEV1 improvement; ↓ respiratory fatigue Moderate ↑ Moderate (RCTs + SR) Pursed-Lip Breathing PEEP effect; ↓ airway collapse; ↓ hyperinflation ↓ Dyspnoea; ↑ O₂ saturation; ↑ FEV1/FVC Mild–Moderate ↑ Moderate (RCTs) Buteyko Technique Correct hypocapnia; ↓ bronchospasm; nasal breathing ↓ Bronchodilator use; ↓ symptoms Variable Moderate (Cochrane) Pranayama (Yoga) Autonomic modulation; ↑ nasal NO; expiratory muscle training FEV1, PEFR, QoL improvement; ↓ anxiety Significant ↑ Moderate–High (Meta-analysis) Multimodal (Combined) Synergistic: all above mechanisms combined Superior outcomes vs single modality Largest ↑ High (Large RCTs) PEEP = Positive End-Expiratory Pressure; NO = Nitric Oxide; QoL = Quality of Life; SR = Systematic Review; RCT = Randomised Controlled Trial. 5. AN INTEGRATIVE PHYSIOLOGICAL FRAMEWORK FOR BREATHING EXERCISE THERAPY IN ASTHMA Based on our synthesis of the evidence, we propose a three-domain physiological framework through which breathing exercises produce their therapeutic effects in asthma: 5.1 Mechanical Domain Breathing exercises improve the mechanical efficiency of the respiratory system by: (i) strengthening the diaphragm and accessory inspiratory/expiratory muscles; (ii) reducing dynamic hyperinflation and air trapping; (iii) restoring optimal thoracic mechanics; and (iv) improving V/Q matching through redistribution of ventilation. These mechanical improvements directly translate to measurable gains in FVC, FEV1, FEV1/FVC ratio, and PEFR. 5.2 Autonomic-Neuroimmune Domain Controlled breathing exercises — particularly slow-paced and PLB techniques — activate vagal (parasympathetic) pathways, reducing bronchomotor tone and airway reactivity. Pranayama-induced increase in nasal NO provides an additional direct bronchodilatory pathway. Correction of hyperventilation-induced hypocapnia (Buteyko technique) reduces CO₂-sensitive bronchospasm. Collectively, these autonomic and neurochemical effects reduce airway hyperresponsiveness and may modulate the inflammatory milieu through neuroimmune interactions. 5.3 Psychological-Behavioural Domain Breathing exercises reduce anxiety, improve self-efficacy, and enhance the patient's sense of agency over their symptoms. Reduced psychological stress decreases HPA axis activation, limiting stress-induced exacerbations. Improved asthma self-management behaviours — including better medication adherence, improved inhaler technique, and early symptom recognition — further contribute to improved clinical outcomes. This domain explains why subjective asthma control (ACT scores, mMRC dyspnoea) often improves disproportionately relative to spirometric parameters. These three domains are not independent; they interact and reinforce one another, explaining why multimodal programmes that engage all three domains tend to produce superior outcomes compared with single-technique interventions. 6. GLOBAL CLINICAL TRIAL AND META-ANALYSIS EVIDENCE Table 2 summarises selected landmark and contemporary clinical trials and systematic reviews. Table 2. Summary of Key Clinical Trials and Reviews: Breathing Exercises in Asthma Study / Author Design (n) Intervention Duration Key Outcomes Nagarathna & Nagendra (1985)²⁶ RCT (106) Integrated yoga + Pranayama 6 weeks ↑ PEFR +18%; ↓ attack frequency Thomas et al. (2009)³¹ RCT (183) Breathing retraining (Papworth) 12 weeks ↑ QoL; ↓ symptoms; modest FEV1 gain Bowler et al. RCT¹⁹ RCT Buteyko technique 8 weeks ↓ Bronchodilator use; ↑ symptom control Singh et al. (1990)²⁷ RCT (60) Pranayama 6 weeks ↑ FEV1; ↓ airway reactivity Vempati et al. (2009)²⁸ RCT Integrated yoga lifestyle 12 weeks ↑ FVC, FEV1, QoL Freitas et al. (2013)³² Cochrane SR Multiple modalities 4–12 weeks ↑ QoL; inconsistent PFT improvement Cramer et al. (2014)³⁰ Meta-analysis (15 RCTs) Yoga/Pranayama 4–16 weeks ↑ Lung function; ↑ QoL; safe Yang et al. (2016)²⁹ Cochrane (15 RCTs) Yoga Variable ↑ FEV1, FVC, QoL; significant RCT = Randomised Controlled Trial; SR = Systematic Review; PFT = Pulmonary Function Test; QoL = Quality of Life. The majority of high-quality RCTs and systematic reviews demonstrate consistent improvements in asthma-related quality of life, symptom control, and patient-reported outcomes following structured breathing exercise interventions. Improvements in objective spirometric parameters (FEV1, FVC, PEFR) are also reported in most well-designed trials, with the magnitude of effect generally related to intervention intensity, duration, and modality combination. The Cochrane review by Freitas et al. noted that while variability exists, the overall direction of evidence supports the adjunctive role of breathing exercises in asthma management.³² 7. SAFETY, CONTRAINDICATIONS, AND PRACTICAL CONSIDERATIONS Breathing exercises are generally well-tolerated, with a favourable safety profile. Adverse effects are rare and typically minor. Excessive breath-holding manoeuvres (as used in Buteyko training) can cause transient dizziness or light-headedness, particularly in patients with hypocapnia. Forceful exhalation techniques (Kapalbhati) are contraindicated in patients with pneumothorax, severe COPD with bullae, or recent abdominal or thoracic surgery. Patients with severe or unstable asthma should begin breathing exercises under physiotherapist or medical supervision. Session intensity and duration should be gradually increased. Patients should be instructed to discontinue exercise and use rescue bronchodilators if symptoms worsen during a session. Once adequately trained, most techniques can be safely self-administered at home with periodic follow-up. Practical implementation considerations include: initial supervised sessions (minimum 2–3 weeks) to ensure correct technique; provision of written and audiovisual instructional materials; patient exercise diaries for compliance monitoring; and integration with existing asthma action plans. 8. RESEARCH GAPS AND FUTURE DIRECTIONS Despite a growing evidence base, several important research gaps remain: (i) Standardised protocols: There is a lack of consensus on optimal session duration, frequency, modality combination, and intervention length. Standardised protocol development through Delphi consensus or guideline development processes is needed. (ii) Mechanistic studies: Few studies have examined biological mechanisms, including measurement of airway inflammatory biomarkers (FeNO, sputum eosinophils, serum IgE, IL-4, IL-13) following breathing exercise interventions. Such data would clarify whether benefits are primarily mechanical or also involve modulation of airway inflammation. (iii) Long-term follow-up: Most trials assess outcomes at 8–16 weeks. Studies with 12–24-month follow-up are needed to establish sustainability of gains. (iv) Severe asthma: Patients with severe and difficult-to-treat asthma are typically excluded from trials but may have the most to gain from non-pharmacological adjuncts. (v) Digital and telehealth delivery: Smartphone-guided breathing training applications and telerehabilitation platforms offer scalable alternatives to in-person supervision. Rigorous evaluation of these delivery models is warranted. (vi) Paediatric and geriatric populations: Most evidence derives from adult populations. Studies in children and older adults are needed to establish age-specific protocols and outcomes. 9. CLINICAL INTEGRATION RECOMMENDATIONS Based on the available evidence, we recommend the following framework for clinical integration of breathing exercise therapy in asthma: GINA Step Asthma Control Recommended Breathing Exercise Approach Steps 1–2 Well-controlled or mild Optional adjunct: Diaphragmatic breathing education; PLB for symptom relief during exertion Steps 3–4 Partially controlled/moderate Recommended: Structured programme — Diaphragmatic + PLB + Pranayama (30 min/day, 6 days/week, ≥ 8 weeks) Step 5 Uncontrolled/severe (stable) Supervised physiotherapy programme; consider multimodal approach with close monitoring All Steps Psychological comorbidity Mindfulness breathing, Anulom-Vilom; stress reduction techniques GINA = Global Initiative for Asthma. Recommendations based on synthesis of available clinical evidence. The minimum effective programme appears to be 30 minutes daily, 5–6 days per week, for at least 8 weeks. Initial supervised sessions (at least 3–6 sessions) with a trained physiotherapist are strongly recommended to ensure correct technique and prevent adverse effects. Adherence monitoring via exercise diaries or digital applications is essential, given the established dose-response relationship between compliance and benefit.

Breathing exercise modalities — diaphragmatic breathing, pursed-lip breathing, Buteyko technique, and Pranayama — each offer distinct, mechanistically grounded contributions to asthma management. Through complementary physiological pathways spanning respiratory biomechanics, autonomic-neuroimmune regulation, and psychological modulation, these techniques address multiple dimensions of asthma pathophysiology that are not targeted by pharmacological therapy alone. The clinical evidence, while heterogeneous in protocol design, consistently supports significant improvements in asthma control, quality of life, and — particularly in adequately powered multimodal programmes — objective pulmonary function parameters. Multimodal structured programmes combining two or more techniques appear to offer superior outcomes compared with single-modality interventions. Breathing exercise therapy represents a cost-effective, safe, accessible, and patient-empowering adjunct to standard asthma management. Its integration into routine clinical practice — supported by physiotherapist referral pathways, pulmonary rehabilitation programmes, and digital health delivery platforms — has the potential to meaningfully reduce the disease burden of asthma at both the individual and population level.

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78. 2. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–78. 3. Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010;3(3):514–40. 4. Freitas DA, Holloway EA, Bruno SS, et al. Breathing exercises for adults with asthma. Cochrane Database Syst Rev. 2013;(10):CD001277. 5. Thomas M, McKinley RK, Mellor S, et al. Breathing exercises for asthma: a randomised controlled trial. Thorax. 2009;64(1):55–61. 6. Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673–83. 7. Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med. 2003;168(1):10–48. 8. Bharshankar JR, Bharshankar RN, Deshpande VN, et al. Effect of yoga on cardiovascular system in subjects above 40 years. Indian J Physiol Pharmacol. 2003;47(2):202–6. 9. Han JN, Stegen K, Simkens K, et al. Unsteadiness of breathing in patients with hyperventilation syndrome and anxiety disorders. Eur Respir J. 1997;10(1):167–76. 10. Cahalin LP, Braga M, Matsuo Y, Hernandez ED. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2002;22(1):7–21. 11. Gosselink RA, Wagenaar RC, Rijswijk H, et al. Diaphragmatic breathing reduces efficiency of breathing in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;151(4):1136–42. 12. Lopes EA, Fanelli-Galvani A, Prisco CC, et al. Assessment of muscle shortening and static posture in children with persistent asthma. Eur J Pediatr. 2007;166(7):715–21. 13. Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis. 2004;1(3):163–72. 14. Mueller RE, Petty TL, Filley GF. Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol. 1970;28(6):784–9. 15. Tiep BL, Burns M, Kao D, et al. Pursed lips breathing training using ear oximetry. Chest. 1986;90(2):218–21. 16. Breslin EH. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest. 1992;101(1):75–8. 17. Spahija J, de Marchie M, Grassino A. Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest. 2005;128(2):640–50. 18. Lum LC. Hyperventilation: the tip and the iceberg. J Psychosom Res. 1975;19(5-6):375–83. 19. Cowie RL, Conley DP, Underwood MF, Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respir Med. 2008;102(5):726–32. 20. Bowler SD, Green A, Mitchell CA. Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust. 1998;169(11-12):575–8. 21. Prem V, Sahoo RC, Adhikari P. Comparison of the effects of Buteyko and pranayama breathing techniques on quality of life in patients with asthma. Clin Rehabil. 2013;27(2):133–41. 22. Bruton A, Lewith GT. The Buteyko breathing technique for asthma: a review. Complement Ther Med. 2005;13(1):41–6. 23. Paul G, Bhattacharya AK, Dey SK. Effect of Anulom-Vilom pranayama on cardiovascular parameters and heart rate variability. J Evol Med Dent Sci. 2014;3(14):3688–95. 24. Weitzberg E, Lundberg JO. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med. 2002;166(2):144–5. 25. Rai B, Kaur J, Anand SC. Effect of pranayama on oxidative stress markers in medical students. J Clin Diagn Res. 2011;5(7):1558–60. 26. Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. Br Med J (Clin Res Ed). 1985;291(6502):1077–9. 27. Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet. 1990;335(8702):1381–3. 28. Vempati R, Bijlani RL, Bhagat OL. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial. BMC Pulm Med. 2009;9:37. 29. Yang ZY, Zhong HB, Mao C, et al. Yoga for asthma. Cochrane Database Syst Rev. 2016;4:CD010346. 30. Cramer H, Posadzki P, Dobos G, Langhorst J. Yoga for asthma: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2014;113(4):383–90. 31. Holloway EA, West RJ. Integrated breathing and relaxation training (the Papworth method) for adults with asthma in primary care: a randomised controlled trial. Thorax. 2007;62(12):1039–42. 32. Freitas DA, Holloway EA, Bruno SS, et al. Breathing exercises for adults with asthma. Cochrane Database Syst Rev. 2013;(10):CD001277.